Author Verified
Published: Sep 2018
ACE Report #10871
Ace Report Cover Cannabis

Titrated THC:CBD Improves Pain and Spasticity Compared to Placebo Over 12 Weeks for Resistant MS

Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Sativex as add-on therapy vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial

Int J Neurosci. 2018 Sep 13:1-10.

Contributing Authors: M Marinelli C Vila JE Markova B Akmaz C Trompke A Lentschat U Essner

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

CME Image

Continuing Medical Education Credits

You could be earning 0.5 CME credits for each report you read.


Please Login or Join to leave comments.